Email from DanSome of you may remember, I emailed Dan a week ago this email:
What's the timing on the ATE/AH amalgamation to be completed? Right now, based on the market cap and share price, looks like there are 45.5million shares outstanding, so I suspect the process has started.
It's frustrating to see a good news report about the IND come out last week only to have no reaction (in fact, share price dropped), so I'm not sure if the market is waiting for this amalgamation to be completed.
I'm just waiting for this stock to take off, or even just rise sustainably, and it seems to be held back for whatever reason. I'd appreciate your thoughts.
He just responded with this...
Thanks for your note... the amalgamation is a priority for us and we look forward to providing an update on the process and timing shortly. The share count figure you are referencing reflects the new issuance of shares from our recent financing. I agree with you regarding the lack of response to the IND announcement but of course we are excited to have FDA clearance to commence human trials in the US. It’s an important milestone that also strengthens our hand in discussions with potential partners as it further de-risks our regulatory path. Thanks as always for your continued support.